Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Tumor immune microenvironment in head and neck cancers.
Chen SMY, Krinsky AL, Woolaver RA, Wang X, Chen Z, Wang JH. Chen SMY, et al. Among authors: krinsky al. Mol Carcinog. 2020 Jul;59(7):766-774. doi: 10.1002/mc.23162. Epub 2020 Feb 3. Mol Carcinog. 2020. PMID: 32017286 Free PMC article. Review.
Divergent outcomes of anti-PD-L1 treatment coupled with host-intrinsic differences in TCR repertoire and distinct T cell activation states in responding versus non-responding tumors.
John J, Woolaver RA, Popolizio V, Chen SMY, Ge H, Krinsky AL, Vashisht M, Kramer Y, Chen Z, Wang JH. John J, et al. Among authors: krinsky al. Front Immunol. 2022 Oct 18;13:992630. doi: 10.3389/fimmu.2022.992630. eCollection 2022. Front Immunol. 2022. PMID: 36330507 Free PMC article.
Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers.
Chen SMY, Popolizio V, Woolaver RA, Ge H, Krinsky AL, John J, Danis E, Ke Y, Kramer Y, Bian L, Nicklawsky AG, Gao D, Liu S, Chen Z, Wang XJ, Wang JH. Chen SMY, et al. Among authors: krinsky al. J Exp Clin Cancer Res. 2022 Apr 2;41(1):123. doi: 10.1186/s13046-022-02337-x. J Exp Clin Cancer Res. 2022. PMID: 35366939 Free PMC article.
Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
Woolaver RA, Wang X, Krinsky AL, Waschke BC, Chen SMY, Popolizio V, Nicklawsky AG, Gao D, Chen Z, Jimeno A, Wang XJ, Wang JH. Woolaver RA, et al. Among authors: krinsky al. J Immunother Cancer. 2021 Jan;9(1):e001615. doi: 10.1136/jitc-2020-001615. J Immunother Cancer. 2021. PMID: 33414263 Free PMC article.